Most countries no longer accept applications for new Covid vaccines. Only accept applications for boosters. I believe the Chinese are still waiting for our IND. How do they start clinical trials without IND approval? If there is no first product to prove the iikey platform, I don't think the Chinese will move on the rest. I have read their contracts many times. Our world-class management team once again missed the opportunity...
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links